Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Biotech Regeneron...

    Biotech Regeneron Pharmaceuticals replaces Intel as sponsor of Science Talent Search

    Written by savita thakur thakur Published On 2016-05-30T16:52:43+05:30  |  Updated On 30 May 2016 4:52 PM IST
    Biotech Regeneron Pharmaceuticals replaces Intel as sponsor of Science Talent Search

    Biotech company Regeneron Pharmaceuticals Inc became the title sponsor of the most prestigious U.S. science competition for high school students, taking the baton from chipmaker Intel Corp.


    Regeneron pledged $100 million to support the Science Talent Search and related programs through 2026, and doubled awards for the top 300 scientists and their schools, to $2,000 each.


    Regeneron's two top executives competed in the annual event during the 1970s and went on to build one of the world's biggest biotech companies, with cutting-edge drugs for fighting macular degeneration, cancer and cholesterol.


    The fast-growing biotech company will take over as named sponsor from Intel, whose chips were helping build the personal computer industry in 1998 when it took over as sponsor from Westinghouse. That storied electronics and industrial giant had sponsored the talent search from 1942 to 1997.


    The competition, overseen by the nonprofit Society for Science & the Public, receives applications annually from more than 1,800 high school seniors, along with their original research in all areas of science, including mathematics.


    The field is winnowed to 300 young scientists, among whom 40 become finalists for a competition in Washington, D.C.


    Regeneron Chief Executive Len Schleifer competed in the Westinghouse Science Talent Search in 1970 with a project on Euclidian geometry. Company research chief George Yancopoulos was a top winner in 1976 for research that involved cutting protozoans in half to see what factors enabled the tiny organisms to regenerate.


    The young scholars stuck to the regeneration theme when Schleifer started Regeneron in 1988, with Yancopoulos its founding scientist. The company focused on discovering nerve-growth proteins that could regenerate neurons. They hoped to find cures for Parkinson's disease and Alzheimer's disease.


    Those lofty efforts failed, but the company kept the Regeneron name as it changed course and focused on other diseases.


    A teacher at Forest Hills High School, in Queens, New York, encouraged Schleifer to enter the Westinghouse competition and gave him inspiration that has lasted a lifetime.


    "It taught me the value of having a teacher who really cared and served as my mentor," said Schleifer. He expressed concern that many fine young scientific minds have been lost over recent decades to more-glamorous fields like investment banking, but said the Regeneron Science Talent Search will hopefully keep many others on track.


    Intel in March said its sponsorship would be ending but provided no details. Company executives declined further comment on Wednesday, including whether the discontinued sponsorship was related to austerity moves as Intel moves forward with 12,000 planned job cuts globally.

    Alzheimer's diseaseIntelParkinson's diseaseRegeneronRegeneron PharmaceuticalsU S science competition for high school
    Source : REUTERS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok